Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:727-728

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christy, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christy, B. A.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:727.)
© 2001 American Heart Association, Inc.


Editorials

A Role for an Alternatively Spliced Id3 Isoform in Vascular Lesions?

Barbara A. Christy

From the Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio.

Correspondence to Dr Barbara Christy, Institute of Biotechnology, UT Health Science Center at San Antonio, 15355 Lambda Dr, San Antonio, TX 78245. E-mail christy@uthscsa.edu


Key Words: helix-loop-helix • vascular smooth muscle • alternative splicing • atherosclerosis

Alterations in proliferation, migration, and function of vascular smooth muscle cells (SMCs) are important in the formation of atherosclerotic and restenotic lesions.1 Although of tremendous clinical importance, the precise molecular mechanisms controlling the proliferation and differentiation of SMCs are not completely understood. Regulation of growth and differentiation in skeletal and cardiac muscle involves a class of transcription factors called helix-loop-helix (HLH) proteins, but the situation in smooth muscle is less clear. The study by Matsumura et al2 in this issue of Arteriosclerosis, Thrombosis, and Vascular Biology investigates a particular HLH protein in vascular SMCs in culture and in vivo after vascular injury.

HLH transcriptional regulatory proteins are implicated in control of cell growth and terminal differentiation in a number of cell types.3 The HLH motif mediates dimer formation among HLH proteins. Most HLH proteins contain a region of basic amino acids adjacent to the HLH domain that constitutes the DNA-binding domain; heterodimers or homodimers of basic HLH (bHLH) proteins generally bind to a conserved DNA binding site (E-box). A subfamily of HLH proteins (Inhibitor of DNA binding [Id] proteins) contain an HLH dimerization domain but lack the basic region and thus are not able to bind DNA.4 Id proteins interact with selected DNA-binding bHLH proteins and negatively regulate their transcriptional activity by preventing formation of functional DNA-binding dimers. Although other potential Id protein functions and interactions have been described,4 this dominant negative activity is thought to be a major mechanism of Id protein action. Four members of . . . [Full Text of this Article]